Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 300.33 Million |
| Market Size (2030) | USD 341.46 Million |
| Growth Rate (2025 - 2030) | 2.60% CAGR |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Middle East Nuclear Imaging Market Analysis by Mordor Intelligence
The Middle East Nuclear Imaging Market size is estimated at USD 300.33 million in 2025, and is expected to reach USD 341.46 million by 2030, at a CAGR of 2.60% during the forecast period (2025-2030).
The COVID-19 pandemic impacted the market studied, as hospital and healthcare services were drastically curtailed due to social distancing measures implemented by Middle East governments. Furthermore, COVID-19 significantly impacted the worldwide economy and the operation of general hospital treatment for non-COVID-19 patients in hospitals around the region. According to a study published in the Journal of Nuclear Medicine in June 2022, oncological PET studies exhibited a lower reduction in utilization compared to standard nuclear medicine tests. The supply lines of radioisotopes, generators, and other vital commodities gradually returned to pre-COVID-19 levels. Overall, pandemic-related issues led to a significant decline in nuclear medicine diagnostic and therapeutic procedures in the Middle East in 2020, thereby impacting the market's growth. However, since the restrictions were lifted, the industry has been recovering well. Over the last few years, market recovery has been led by the high prevalence of diseases, demand for nuclear imaging diagnosis, and new product launches.
The rise in the prevalence of cancer and cardiac ailments is one of the primary drivers of market growth. Nuclear medicine is hugely capable of treating cancer and cardiac diseases. The cancer burden is increasing owing to factors such as the aging population, poor diet, smoking, and physical inactivity. Since the advent of contemporary technology, nuclear medicine imaging has considerably aided in the diagnosis, planning of treatment, and assessment of treatment response in cancer patients, which is expected to drive its demand over the forecast period. According to GLOBOCAN 2020, an estimated 28,704 new cancer cases were reported in Israel, and 27,885 new cancer cases were reported in Saudi Arabia. With the rising incidence of cancer, the magnetic resonance imaging market in the Middle East region is estimated to witness healthy growth during the forecast period. Nuclear medicine plays an important role in the diagnosis and management of patients with several diseases, which is a key growth factor for the market studied.
Middle East Nuclear Imaging Market Trends and Insights
Oncology Segment is Expected to Grow at a Higher CAGR During the Forecast Period
The major factors responsible for the growth of this segment include the rise in the prevalence of cancers that require advanced diagnostics like PET/CT scans. According to the Global Cancer Observatory (Globocan) Statistics for 2020, the 5-year prevalence of all types of cancers in both sexes in Saudi Arabia was 82,640. Out of these cases, 39,241 were reported in males and 43,399 in females of all ages. The significant prevalence of cancer in the Middle East region is expected to drive market growth during the forecast period.
The fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT scan is more sensitive than a contrast-enhanced CT scan in staging several types of lymphoma and detecting tumor dissemination in various solid cancers, including breast cancer, lung cancer, and colon cancer. The further launch of awareness campaigns to create awareness about cancer in the country will also increase demand for cancer diagnostic modalities, thereby augmenting the market. For instance, in October 2021, the Ministry of Health (MOH) launched an awareness campaign on early screening of breast cancer, which is the most common cancer among Saudi women. Hence, due to the abovementioned factors, the oncology segment of the market is expected to witness growth over the forecast period.
Competitive Landscape
The Middle East nuclear imaging market is highly competitive, comprising a few major players. The key players in the Middle East nuclear imaging market are Bracco Imaging SpA, Cardinal Health Inc., Curium, GE Healthcare, Koninklijke Philips NV, NTP Radioisotopes SOC Ltd, Siemens AG, and Toshiba Corporation.
Middle East Nuclear Imaging Industry Leaders
-
Bracco Imaging SpA
-
Cardinal Health Inc.
-
GE Healthcare
-
Koninklijke Philips N.V
-
Siemens AG
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- October 2022: Integrated Diagnostics Holdings PLC announced that its radiology venture, Al-Borg Scan, received the American College of Radiology accreditation for its nuclear medicine and ultrasound units.
- March 2022: The Arab States strengthed cooperation in nuclear medicine and science. The concurrent MoU signings were a first of their kind for ARASIA and enabled the most technically-advanced Arab countries to support their neighbors in nuclear medicine, calibration of instrumentation, and in dosimetry and ensuring safety from ionizing radiation.
Middle East Nuclear Imaging Market Report Scope
Nuclear medicine imaging procedures are non-invasive, except for the intravenous injections, and are typically painless medical tests that help physicians diagnose and evaluate various medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers, which are used in diagnosis and therapeutics. These small substances contain radioactive substances used to treat cancer, cardiac, and neurological disorders.
The Middle East nuclear imaging market is segmented by Product (Equipment, Radioisotopes), Application (SPECT Applications (Cardiology, Neurology, Thyroid, Other SPECT Applications), PET Applications (Cardiology, Neurology, Oncology, Other PET Applications)), and Geography (Saudi Arabia, United Arab Emirates, Egypt, Iran, Rest of the Middle East). The report offers the value in USD million for the above segments.
By Product
| Equipment |
| Radioisotope |
By Application
| SPECT Applications | Cardiology |
| Neurology | |
| Thyroid | |
| Other SPECT Applications | |
| PET Applications | Cardiology |
| Neurology | |
| Oncology | |
| Other PET Applications |
Geography
| Saudi Arabia |
| United Arab Emirates |
| Egypt |
| Iran |
| Rest of Middle East |
| By Product | Equipment | |
| Radioisotope | ||
| By Application | SPECT Applications | Cardiology |
| Neurology | ||
| Thyroid | ||
| Other SPECT Applications | ||
| PET Applications | Cardiology | |
| Neurology | ||
| Oncology | ||
| Other PET Applications | ||
| Geography | Saudi Arabia | |
| United Arab Emirates | ||
| Egypt | ||
| Iran | ||
| Rest of Middle East | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the Middle East Nuclear Imaging Market?
The Middle East Nuclear Imaging Market size is expected to reach USD 300.33 million in 2025 and grow at a CAGR of 2.60% to reach USD 341.46 million by 2030.
What is the current Middle East Nuclear Imaging Market size?
In 2025, the Middle East Nuclear Imaging Market size is expected to reach USD 300.33 million.
Who are the key players in Middle East Nuclear Imaging Market?
Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips N.V and Siemens AG are the major companies operating in the Middle East Nuclear Imaging Market.
What years does this Middle East Nuclear Imaging Market cover, and what was the market size in 2024?
In 2024, the Middle East Nuclear Imaging Market size was estimated at USD 292.52 million. The report covers the Middle East Nuclear Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Middle East Nuclear Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
